ALFA Finder| Margins | Targeting 62% IVD, 45% MedTech, and 12% Solar EPC gross margins. |
|---|---|
| Order book | ₹3,000+ Cr renewable energy pipeline; ~₹2,000 Cr currently secured. |
| Demand visibility | Strong; backed by National Solar Mission and National Sickle Cell Mission. |
| Management confidence | High; citing 27-year legacy and strategic pivots into high-margin segments. |
Growth
No Q1 FY27 specific financials provided; highlights include securing a maiden $1M US export order and 20.8% CAGR MedTech market tailwinds.
Outlook
Vision 2030 targets $3B valuation, 2,000+ pathology labs, and 1,000 renal units by March 2028. FY27 FPO and FY28 demerger planned.
Risks
Dependence on government contracts (UPNEDA, BREDA) and high import substitution requirements in the Indian medical device sector.
Investor Presentation filed with BSE, NSE: KRATOSENER. Summary written with AI assistance from the document.
Lords Mark Industries Ltd: key numbers
- Share price
- ₹80.05
- Market cap
- ₹3,415 Cr
- Revenue (annual)
- ₹684.8 Cr
- Net profit (annual)
- ₹48.59 Cr
- P/E (TTM)
- 40.9×Sector 20.8×
- Promoter holding
- 75.30%-4.54% QoQ
- FII holding
- 1.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lords Mark Industries Ltd
All →Lords Mark Industries Board Meeting Date
Lord's Mark Industries Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Lords Mark Industries Business Update
Lord's Mark showcased defence products from its investee Brahamastra, including BRAK RT and TRC-1. The promotional release discloses no orders, revenue, or quantified investment amount.
Lords Mark Industries Preferential Issue
Lord's Mark Industries seeks approval for a promoter loan of up to ₹100 Crore convertible into equity via postal ballot. E-voting closes November 25, 2026.
Lords Mark Industries Debt & Borrowing: ₹100 Cr
Lord's Mark Industries approved a ₹100 Crore convertible loan from promoter MD Upadhyay. Shareholder approval will be sought via postal ballot by November 27, 2026.
- Value
- ₹100.0 Cr
Lords Mark Industries Capacity Expansion
Lord’s Mark Industries completed its Silvassa manufacturing capacity expansion ahead of schedule. The company also secured US FDA registration for over 200 surgical and hygiene products.
Lords Mark Industries Fund Raise of ₹100 Cr
Lord's Mark Industries will hold a board meeting on October 23, 2026, to consider raising a Rs. 100 Crore unsecured convertible loan from its promoter.
- Value
- ₹100.0 Cr